Errata

NOVEMBER 01, 2004

The article on Home Diagnostic Kits in the September 2004 issue of Pharmacy Times should have said that the FDA has cleared home testing kits for consumer use.

The article on Fluoroquinolones in the September issue should have referred to nalidixic acid as a quinolone.

An error in editing resulted in misinformation in the article, Statins and Diabetes (October 2004). The table should have said that there are currently 6 statins on the market. Ezetimibe (Zetia) and the combination product ezetimibe/simvastatin (Vytorin) should not have been included.



SHARE THIS SHARE THIS
0

Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.